2004
DOI: 10.1001/archotol.130.1.105
|View full text |Cite
|
Sign up to set email alerts
|

Positron Emission Tomography in the Early Follow-up of Advanced Head and Neck Cancer

Abstract: Whole-body PET scanning approximately 6 weeks after completion of a combined treatment regimen with radiation and chemotherapy can reliably identify locoregional residual cancer and distant metastases or secondary tumors in patients with advanced-stage HNSCC and has a direct influence on management decisions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
60
0
4

Year Published

2004
2004
2014
2014

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 120 publications
(66 citation statements)
references
References 17 publications
2
60
0
4
Order By: Relevance
“…Therefore, the specificity and false-positive rates should be considered critically in comparison with other studies that report only a single scan in a treated patient. 10,11,[24][25][26][27][28][29][30][31][32][33] In a recent meta-analysis of studies investigating the effectiveness of a single PET scan after RT that included patients with suspected disease recurrence, the sensitivity, specificity, positive predictive value, and negative predictive value were 94%, 82%, 75%, and 95%, respectively. 25 In our experience, false-positive findings in the head and neck remain an issue for PET or PET/CT in the followup care of patients with head and neck cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, the specificity and false-positive rates should be considered critically in comparison with other studies that report only a single scan in a treated patient. 10,11,[24][25][26][27][28][29][30][31][32][33] In a recent meta-analysis of studies investigating the effectiveness of a single PET scan after RT that included patients with suspected disease recurrence, the sensitivity, specificity, positive predictive value, and negative predictive value were 94%, 82%, 75%, and 95%, respectively. 25 In our experience, false-positive findings in the head and neck remain an issue for PET or PET/CT in the followup care of patients with head and neck cancer.…”
Section: Discussionmentioning
confidence: 99%
“…37,[40][41][42] However, due to inflammatory uptake, a positive PET/CT result in the head and neck must be correlated with the physical examination and a tissue biopsy may be warranted.…”
Section: Evaluation Of Therapy Responsementioning
confidence: 99%
“…50 In the setting of surveillance, numerous studies have demonstrated that 18 F-FDG-PET/CT has a relatively high sensitivity for detecting recurrent disease at the primary tumor site and regional lymph node metastases. 37,[38][39][40][41][42][43][44][45][49][50][51][52] For patients who underwent PET or PET/CT at least 12 weeks after the completion of all therapy, the reported sensitivity ranged between 90% and 100% for the detection of recurrence. Due to nonspecific inflammatory uptake, the specificity of PET and PET/CT is between 63% and 94%, and a tissue biopsy or shortinterval repeat scanning is warranted.…”
Section: Evaluation Of Recurrence and Surveillancementioning
confidence: 99%
“…Elle peut être utilisée pour le diagnostic, le bilan initial [5,6], la surveillance après le traitement [7] et la mise en évidence des récidives [8].…”
Section: Indications De La Tep-fdg Et De La Tep-tdmunclassified